Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Mesa Laboratories (MLAB) EBT Margin (2016 - 2025)

Mesa Laboratories (MLAB) has disclosed EBT Margin for 16 consecutive years, with 7.06% as the latest value for Q4 2025.

  • Quarterly EBT Margin rose 1059.0% to 7.06% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 5.68% through Dec 2025, up 11918.0% year-over-year, with the annual reading at 2.47% for FY2025, 12998.0% up from the prior year.
  • EBT Margin hit 7.06% in Q4 2025 for Mesa Laboratories, up from 3.29% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 12.89% in Q1 2021 to a low of 467.42% in Q1 2024.
  • Historically, EBT Margin has averaged 20.61% across 5 years, with a median of 3.41% in 2022.
  • Biggest five-year swings in EBT Margin: tumbled -46693bps in 2024 and later soared 46817bps in 2025.
  • Year by year, EBT Margin stood at 4.28% in 2021, then skyrocketed by 182bps to 3.53% in 2022, then rose by 3bps to 3.64% in 2023, then plummeted by -197bps to 3.53% in 2024, then surged by 300bps to 7.06% in 2025.
  • Business Quant data shows EBT Margin for MLAB at 7.06% in Q4 2025, 3.29% in Q3 2025, and 11.78% in Q2 2025.